Reuters logo
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg
December 5, 2016 / 10:01 PM / a year ago

Sanofi exploring bid for Actelion amid J&J talks - Bloomberg

Dec 5 (Reuters) - Sanofi is considering a bid for Swiss biotech company Actelion, rivaling an offer made by U.S. healthcare company Johnson & Johnson, Bloomberg reported, citing people familiar with the matter.

J&J said last month it was in preliminary talks with Actelion about a potential takeover of Europe's largest biotech firm, which was then valued at about $20 billion. (

Lung disease specialist Actelion has confirmed the J&J offer but has warned there is no certainty of a deal.

Sanofi, J&J and Actelion were not immediately available for comments. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju Samuel)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below